Elevation Wealth Partners’s Gilead Sciences GILD Stock Holding History

Elevation Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Buy	1,235 +107	+9%	+$14.1K	0.05%	156
2026 Q1	$157K	Sell	1,128 -125	-10%	-$17.5K	0.06%	132
2025 Q4	$154K	Buy	1,253 +145	+13%	+$17.6K	0.05%	132
2025 Q3	$123K	Buy	1,108 +77	+7%	+$8.75K	0.04%	156
2025 Q2	$114K	Hold	1,031	–	–	0.05%	160
2025 Q1	$101K	Hold	1,031	–	–	0.04%	170
2024 Q4	$95.2K	Hold	1,031	–	–	0.04%	174
2024 Q3	$86.4K	Hold	1,031	–	–	0.04%	178
2024 Q2	$70.7K	Hold	1,031	–	–	0.03%	186
2024 Q1	$81.1K	Sell	1,031 -50	-5%	-$3.85K	0.04%	179
2023 Q4	$85.4K	Hold	1,081	–	–	0.05%	166
2023 Q3	$81K	Hold	1,081	–	–	0.07%	113
2023 Q2	$83.3K	Sell	1,081 -116	-10%	-$9.25K	0.07%	115
2023 Q1	$99.3K	Buy	+1,197	New	+$99.1K	0.09%	103

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Elevation Wealth Partners's GILD Position: Q2 2026 in Review

Elevation Wealth Partners increased its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, buying an estimated $14.1K and bringing the position to 1,235 shares worth $156K. The position accounts for 0.05% of the portfolio, ranked #156.

Elevation Wealth Partners first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. The position peaked at $157K in Q1 2026. 907 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Elevation Wealth Partners held 1,235 shares of Gilead Sciences worth $156K as of Q2 2026.
Elevation Wealth Partners bought 107 Gilead Sciences shares in Q2 2026, an estimated $14.1K.
Gilead Sciences made up 0.05% of Elevation Wealth Partners's portfolio in Q2 2026, its #156 holding.
Elevation Wealth Partners first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
Elevation Wealth Partners's Gilead Sciences position peaked at $157K in Q1 2026.
907 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.